InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Aug 2, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Aug 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulation-fd, disclosure
TL;DR
InfuSystem Holdings filed an 8-K for a Reg FD disclosure. No specific details yet.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on August 2, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a standard current report filed with the SEC.
Why It Matters
This filing indicates InfuSystem Holdings is making a public disclosure required by Regulation FD, ensuring all investors receive material information simultaneously.
Risk Assessment
Risk Level: low — This is a routine regulatory filing without immediate financial implications or significant new information.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- August 2, 2024 (date) — Filing Date
- Regulation FD (regulation) — Disclosure Type
- Rochester Hills, Michigan (location) — Principal Executive Offices
- HAPC, Inc. (company) — Former Company Name
FAQ
What is the specific nature of the Regulation FD Disclosure being made by InfuSystem Holdings?
The provided filing does not specify the details of the Regulation FD Disclosure, only that it is being made.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on August 2, 2024.
What is the principal executive office address for InfuSystem Holdings?
The principal executive offices are located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
Has InfuSystem Holdings previously operated under different names?
Yes, the company was formerly known as HAPC, Inc. and Healthcare Acquisition Partners Corp.
What is the SIC code for InfuSystem Holdings?
The Standard Industrial Classification (SIC) code is 3841 for SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-08-02 16:30:26
Filing Documents
- infu-20240802.htm (8-K) — 28KB
- exhibit991announcementofea.htm (EX-99.1) — 8KB
- infusystem_safesmarttruste.jpg (GRAPHIC) — 760KB
- 0001628280-24-034443.txt ( ) — 1197KB
- infu-20240802.xsd (EX-101.SCH) — 2KB
- infu-20240802_lab.xml (EX-101.LAB) — 21KB
- infu-20240802_pre.xml (EX-101.PRE) — 12KB
- infu-20240802_htm.xml (XML) — 3KB
01 - Regulation FD
Item 7.01 - Regulation FD On August 2, 2024 , InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that the Company will disclose its financial results for the second quarter 2024 on Thursday, August 8, 2024 before the market opens. The Company will also conduct a conference call for all interested investors on Thursday, August 8, 2024 at 9:00 a.m. Eastern Time. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated August 2 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Richard DiIorio Richard DiIorio Chief Executive Officer and Director Dated: August 2, 2024